• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Cari Bruins, PharmD

Latest:

Molecular Testing Patterns in Metastatic Non—Small Cell Lung Cancer

Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.


Natasha B. Leighl, MD

Latest:

Closing the Personalized Medicine Information Gap: HER2 Test Documentation Practice

Despite universal access to HER2 testing in Ontario, variability in reporting by region and disease severity presents challenges for program evaluation and quality improvement initiatives.


Kent Bradley, MD, MPH, MBA

Latest:

Reference-Based Pricing: An Evidence-Based Solution for Lab Services Shopping

Reference-based pricing combined with employer education and an online shopping tool significantly improved members' utilization of lab services at or below the reference price



Kyunghwa Park, PharmD

Latest:

Impact of Switching Analogue Insulin to Human Insulin in Diabetes

Converting from analogue insulin to human insulin is associated with a clinical insignificant increase in glycated hemoglobin of 0.16% but with improved insulin adherence.


Meiqi He, MS

Latest:

Number of Manufacturers and Generic Drug Pricing From 2005 to 2017

Regardless of the number of manufacturers, generic drug prices presented double-digit average increases from 2012 to 2015.


Amy Tenderich

Latest:

Payer's Role in Care: Gatekeeper or Change Agent?

The panel discussion for Session 3, "The Role of Health Plans and Payers in Patient Care," discussed the role of payers in revolutionizing the system to make it patient-centric.







Lihao Chu, PhD

Latest:

Identifying Chronic Kidney Disease Stage 3 With Excess Disease Burden

A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology intervention.


Megan Savage, BS

Latest:

The Role of Nurse Practitioners in Primary Healthcare

The potential of nurse practitioners is not being fully realized in primary care medical practices. Consequently, cost and quality gains are not being achieved.


Michael L. Johnson, PhD

Latest:

VHA Pharmacy Use in Veterans With Medicare Drug Coverage

Greater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.



Rajiv Gulati, MD, PhD

Latest:

Economic and Clinical Impact of Routine Weekend Catheterization Services

Weekend cardiac catheterization availability for inpatients reduced length of stay and maintained quality of care (no excess hazard for weekend cases), but costs were similar.







Arnold N. F. Degboe, MB, ChB, PhD

Latest:

Hypertension Control in Ambulatory Care Patients With Diabetes

This paper explores hypertension control among patients with diabetes in a variety of ambulatory care settings. We also consider the role of sociodemographic factors.


Stephen D. Persell, MD, MPH

Latest:

Implementation of EHR-Based Strategies to Improve Outpatient CAD Care

We examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.


Joshua J. Ofman, MD, MSHS

Latest:

Novel Multicancer Early Detection Technology––Potential Value to Employers and the Workforce

Multicancer early detection technology could help reduce cancer mortality compared to the current strategy of single-cancer screening tests.



Brian Schmotzer, MS

Latest:

Improving Medication Understanding Among Latinos Through Illustrated Medication Lists

A randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.



© 2024 MJH Life Sciences
AJMC®
All rights reserved.